The U.S. Food and Drug Administration (FDA) on Thursday published more than 200 complete response letters ((CRLs)), through ...

Merck has claimed the first-ever FDA approval for an Ebola vaccine, a few weeks after a green light in Europe, as stockpiling efforts build ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

Verona Pharma’s flagship drug last year became the first new maintenance treatment for chronic obstructive pulmonary disease ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

A new slate of vaccine advisers to the US Centers for Disease Control and Prevention voted Thursday to recommend that ...

The revamped and “more anti-vax skewed ACIP committee” at the CDC “has a bone to pick with mRNA vaccines,” according to ...

The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F.

The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review ...

Merck MRK announced FDA approval for its prophylactic long-acting monoclonal ... the antibody early in the third quarter of 2025. While there are multiple vaccines approved for preventing RSV in the ...

As if to address the concerns of both groups, Kennedy's FDA announced in May that it approves covid boosters only for those over 65 or in other high-risk groups. The vaccine remains available to ...